Trabajos de Daniel Castellano

Clinical Medicine


  Listando 69 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   391   News   0   Policy
Article Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma Powles, Thomas; Rosenberg, Jonathan E.; Sonpavde, Guru P.; Loriot, Yohann; Duran, Ignacio; Lee, Jae-Lyun; Matsubara, Nobuaki; Vulsteke, Christof; Castellano, Daniel; Wu, Chunzhang; Campbell, Mary; Matsangou, Maria; Petrylak, Daniel P. NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2021) DOI / 10.1056/nejmoa2035807
Mentions   0   Wikipedia   129   News   0   Policy
Article Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study Conteduca, V.; Wetterskog, D.; Sharabiani, M. T. A.; Grande, E.; Fernandez-Perez, M. P.; Jayaram, A.; Salvi, S.; Castellano, D.; Romanel, A.; Lolli, C.; Casadio, V.; Gurioli, G.; Amadori, D.; Font, A.; Vazquez-Estevez, S.; Gonzalez Del Alba, A.; Mellado, B ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx155 Green published, Gold other
Mentions   0   Wikipedia   103   News   3   Policy
Article Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer de Wit, Ronald; de Bono, Johann; Sternberg, Cora N.; Fizazi, Karim; Tombal, Bertrand; Wuelfing, Christian; Kramer, Gero; Eymard, Jean-Christophe; Bamias, Aristotelis; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdottir, Asgerdur; Theodore, NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2019) DOI / 10.1056/nejmoa1911206 Bronze, Green published
Mentions   0   Wikipedia   78   News   0   Policy
Article ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Powles, Thomas; Assaf, Zoe June; Davarpanah, Nicole; Banchereau, Romain; Szabados, Bernadett E.; Yuen, Kobe C.; Grivas, Petros; Hussain, Maha; Oudard, Stephane; Gschwend, Jurgen E.; Albers, Peter; Castellano, Daniel; Nishiyama, Hiroyuki; Daneshmand, Siamak NATURE 0028-0836 (2021) DOI / 10.1038/s41586-021-03642-9
Mentions   0   Wikipedia   14   News   1   Policy
Article Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial Powles, Thomas; Duran, Ignacio; van der Heijden, Michiel S.; Loriot, Yohann; Vogelzang, Nicholas J.; De Giorgi, Ugo; Oudard, Stephane; Retz, Margitta M.; Castellano, Daniel; Bamias, Aristotelis; Flechon, Aude; Gravis, Gwenaelle; Hussain, Syed; Takano, Tosh LANCET 0140-6736 (2018) DOI / 10.1016/s0140-6736(17)33297-x
Mentions   0   Wikipedia   4   News   0   Policy
Article Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial Powles, Thomas; Kockx, Mark; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; van der Heijden, Michiel S.; Szabados, Bernadett; Pous, Albert Font; Gravis, Gwenaelle; Anido Herranz, Urbano; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Jose Mende NATURE MEDICINE 1078-8956 (2019) DOI / 10.1038/s41591-019-0628-7 Green accepted
Mentions   0   Wikipedia   13   News   3   Policy
Article First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study Balar, Arjun V.; Castellano, Daniel; O'Donnell, Peter H.; Grivas, Petros; Vuky, Jacqueline; Powles, Thomas; Plimack, Elizabeth R.; Hahn, Noah M.; de Wit, Ronald; Pang, Lei; Savage, Mary J.; Perini, Rodolfo F.; Keefe, Stephen M.; Bajorin, Dean; Bellmunt, Jo LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30616-2
Mentions   0   Wikipedia   4   News   0   Policy
Article Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial Escudier, Bernard; Powles, Thomas; Motzer, Robert J.; Olencki, Thomas; Aren Frontera, Osvaldo; Oudard, Stephane; Rolland, Frederic; Tomczak, Piotr; Castellano, Daniel; Appleman, Leonard J.; Drabkin, Harry; Vaena, Daniel; Milwee, Steven; Youkstetter, Jillia JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2017.74.7352 Green published
Mentions   0   Wikipedia   12   News   0   Policy
Article Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Powles, Thomas; van der Heijden, Michiel S.; Castellano, Daniel; Galsky, Matthew D.; Loriot, Yohann; Petrylak, Daniel P.; Ogawa, Osamu; Park, Se Noon; Lee, Jae-Lyun; De Giorgi, Ugo; Bogemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J.; Gurney, Howard; LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(20)30541-6
Mentions   0   Wikipedia   6   News   0   Policy
Article Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open- Garcia-Donas, Jesus; Font, Albert; Perez-Valderrama, Begona; Antonio Virizuela, Jose; Angel Climent, Miquel; Hernando-Polo, Susana; Angel Arranz, Jose; Del Mar Llorente, Maria; Lainez, Nuria; Carlos Villa-Guzman, Jose; Mellado, Begona; Gonzalez del Alba, A LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30242-5 Green accepted
Mentions   2   Wikipedia   6   News   0   Policy
Article Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA Oudard, Stephane; Fizazi, Karim; Sengelov, Lisa; Daugaard, Gedske; Saad, Fred; Hansen, Steinbjorn; Hjalm-Eriksson, Marie; Jassem, Jacek; Thiery-Vuillemin, Antoine; Caffo, Orazio; Castellano, Daniel; Mainwaring, Paul N.; Bernard, John; Shen, Liji; Chadjaa, JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2017) DOI / 10.1200/jco.2016.72.1068
Mentions   0   Wikipedia   1   News   0   Policy
Article Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status Grivas, Petros; Plimack, Elizabeth R.; Balar, Arjun, V; Castellano, Daniel; O'Donnell, Peter H.; Bellmunt, Joaquim; Powles, Thomas; Hahn, Noah M.; de Wit, Ronald; Bajorin, Dean F.; Ellison, Misoo C.; Frenkl, Tara L.; Godwin, James L.; Vuky, Jacqueline EUROPEAN UROLOGY ONCOLOGY (2020) DOI / 10.1016/j.euo.2020.02.009 Gold other, Green published
Mentions   0   Wikipedia   6   News   0   Policy
Article Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer Vuky, Jacqueline; Balar, Arjun V.; Castellano, Daniel; O'Donnell, Peter H.; Grivas, Petros; Bellmunt, Joaquim; Powles, Thomas; Bajorin, Dean; Hahn, Noah M.; Savage, Mary J.; Fang, Xiao; Godwin, James Luke; Frenkl, Tara L.; Moreno, Blanca Homet; de Wit, Ron JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.19.01213
Mentions   0   Wikipedia   2   News   0   Policy
Article Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma McDermott, David F.; Lee, Jae-Lyun; Ziobro, Marek; Suarez, Cristina; Langiewicz, Przemyslaw; Matveev, Vsevolod Borisovich; Wiechno, Pawel; Gafanov, Rustem Airatovich; Tomczak, Piotr; Pouliot, Frederic; Donskov, Frede; Alekseev, Boris Yakovlevich; Shin, San JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.02365 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study Fizazi, Karim; Kramer, Gero; Eymard, Jean-Christophe; Sternberg, Cora N.; de Bono, Johann; Castellano, Daniel; Tombal, Bertrand; Whuelfing, Christian; Liontos, Michael; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdottir, Asgerdur; Theodore LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(20)30449-6
Mentions   0   Wikipedia   10   News   0   Policy
Article Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial Albiges, Laurence; Tannir, Nizar M.; Burotto, Mauricio; McDermott, David; Plimack, Elizabeth R.; Barthelemy, Philippe; Porta, Camillo; Powles, Thomas; Donskov, Frede; George, Saby; Kollmannsberger, Christian K.; Gurney, Howard; Grimm, Marc-Oliver; Tomita, ESMO OPEN (2020) DOI / 10.1136/esmoopen-2020-001079 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression Segovia, Cristina; San Jose-Eneriz, Edurne; Munera-Maravilla, Ester; Martinez-Fernandez, Monica; Garate, Leire; Miranda, Estibaliz; Vilas-Zornoza, Amaia; Lodewijk, Iris; Rubio, Carolina; Segrelles, Carmen; Vitores Valcarcel, Luis; Rabal, Obdulia; Casares, NATURE MEDICINE 1078-8956 (2019) DOI / 10.1038/s41591-019-0499-y
Mentions   0   Wikipedia   0   News   0   Policy
Article Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study Sternberg, Cora N.; Castellano, Daniel; de Bono, Johann; Fizazi, Karim; Tombal, Bertrand; Wuelfing, Christian; Kramer, Gero; Eymard, Jean-Christophe; Bamias, Aristotelis; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdottir, Asgerdur; Theodo EUROPEAN UROLOGY 0302-2838 (2021) DOI / 10.1016/j.eururo.2021.06.021
Mentions   0   Wikipedia   0   News   0   Policy
Article CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma Escudier, Bernard; Sharma, Padmanee; McDermott, David F.; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Procopio, Giuseppe; Plimack, Elizabeth R.; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Peltola, Katri EUROPEAN UROLOGY 0302-2838 (2017) DOI / 10.1016/j.eururo.2017.02.010 Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial Angel Climent, Miguel; Perez-Valderrama, Begona; Mellado, Begona; Fernandez Parra, Eva Maria; Fernandez Calvo, Ovidio; Ochoa de Olza, Maria; Muinelo Romay, Laura; Anido, Urbano; Domenech, Montserrat; Hernando Polo, Susana; Arranz Arija, Jose Angel; Caballe EUROPEAN JOURNAL OF CANCER 0959-8049 (2017) DOI / 10.1016/j.ejca.2017.09.028
Mentions   0   Wikipedia   0   News   0   Policy
Article Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study Pal, Sumanta K.; McGregor, Bradley; Suarez, Cristina; Tsao, Che-Kai; Kelly, William; Vaishampayan, Ulka; Pagliaro, Lance; Maughan, Benjamin L.; Loriot, Yohann; Castellano, Daniel; Srinivas, Sandy; McKay, Rana R.; Dreicer, Robert; Hutson, Thomas; Dubey, Sar JOURNAL OF CLINICAL ONCOLOGY (2021) DOI / 10.1200/jco.21.00939
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical outcome after progressing to frontline and second-line Anti-PD-1/PD-L1 in advanced urothelial cancer De Liano Lista, Alfonso Gomez; van Dijk, Nick; Oria de Rueda, Guillermo de Velasco; Necchi, Andrea; Lavaud, Pernelle; Morales-Barrera, Rafael; Alonso Gordoa, Teresa; Maroto, Pablo; Ravaud, Alain; Duran, Ignacio; Szabados, Bernadett; Castellano, Daniel; Gia EUROPEAN UROLOGY 0302-2838 (2020) DOI / 10.1016/j.eururo.2019.10.004
Mentions   0   Wikipedia   0   News   0   Policy
Article The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma McKay, Rana R.; Bosse, Dominick; Xie, Wanling; Wankowicz, Stephanie A. M.; Flaifel, Abdallah; Brandao, Raphael; Lalani, Aly-Khan A.; Martini, Dylan J.; Wei, Xiao X.; Braun, David A.; Van Allen, Eliezer; Castellano, Daniel; De Velasco, Guillermo; Wells, J. CANCER IMMUNOLOGY RESEARCH 2326-6066 (2018) DOI / 10.1158/2326-6066.cir-17-0475 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study de Wit, R.; Wuelfing, C.; Castellano, D.; Kramer, G.; Eymard, J. -C.; Sternberg, C. N.; Fizazi, K.; Tombal, B.; Bamias, A.; Carles, J.; Iacovelli, R.; Melichar, B.; Sverrisdottir, A.; Theodore, C.; Feyerabend, S.; Helissey, C.; Foster, M. C.; Ozatilgan, A. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100241 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib De Velasco, Guillermo; Ruiz-Granados, Alvaro; Reig, Oscar; Massari, Francesco; Climent Duran, Miguel Angel; Verzoni, Elena; Graham, Jeffrey; Llarena, Roberto; De Tursi, Michele; Donskov, Frede; Iglesias, Clara; Pandha, Hardev S.; Garcia del Muro, Xavier; P BJU INTERNATIONAL 1464-4096 (2021) DOI / 10.1111/bju.15356
Mentions   0   Wikipedia   0   News   0   Policy
Article CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status Rubio, Carolina; Martinez-Fernandez, Monica; Segovia, Cristina; Lodewijk, Iris; Suarez-Cabrera, Cristian; Segrelles, Carmen; Lopez-Calderon, Fernando; Munera-Maravilla, Ester; Santos, Mirentxu; Bernardini, Alejandra; Garcia-Escudero, Ramon; Lorz, Corina; J CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-18-0685 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity van der Zanden, Loes F. M.; Vermeulen, Sita H.; Oskarsdottir, Arna; Maurits, Jake S. F.; Diekstra, Meta H. M.; Ambert, Valentin; Cambon-Thomsen, Anne; Castellano, Daniel; Fritsch, Achim; Garcia Donas, Jesus; Guarch Troyas, Rosa; Guchelaar, Henk-Jan; Hartma UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 1078-1439 (2017) DOI / 10.1016/j.urolonc.2017.03.009 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer Huddart, Robert A.; Siefker-Radtke, Arlene O.; Balar, Arjun, V; Bilen, Mehmet A.; Powles, Thomas; Bamias, Aristotelis; Castellano, Daniel; Khalil, Maged F.; van der Heijden, Michiel S.; Koshkin, Vadim S.; Pook, David W.; Ozguroglu, Mustafa; Santiago, Linda FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0795 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future Rey-Cardenas, M.; Guerrero-Ramos, F.; de Liano Lista, A. Gomez; Carretero-Gonzalez, A.; Bote, H.; Herrera-Juarez, M.; Carril-Ajuria, L.; Martin-Soberon, M.; Sepulveda, J. M.; Billalabeitia, E. G.; Castellano, D.; De Velasco, G. CANCER TREATMENT REVIEWS 0305-7372 (2021) DOI / 10.1016/j.ctrv.2020.102142
Mentions   0   Wikipedia   0   News   0   Policy
Article Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group Aparicio, J.; Garcia del Muro, X.; Maroto, P.; Terrasa, J.; Castellano, D.; Bastus, R.; Guma, J.; Sagastibeltza, N.; Duran, I; Ochenduszko, S.; Meana, J. A.; Garcia-Sanchez, J.; Arranz, J. A.; Girones, R.; Germa, J. R. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02393-9
Mentions   0   Wikipedia   0   News   0   Policy
Article PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma Roldan-Romero, Juan M.; Beuselinck, Benoit; Santos, Maria; Rodriguez-Moreno, Juan F.; Lanillos, Javier; Calsina, Bruna; Gutierrez, Ana; Tang, Karin; Lainez, Nuria; Puente, Javier; Castellano, Daniel; Esteban, Emilio; Climent, Miguel A.; Arranz, Jose A.; Al INTERNATIONAL JOURNAL OF CANCER 0020-7136 (2019) DOI / 10.1002/ijc.32579
Mentions   0   Wikipedia   0   News   0   Policy
Article Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study) Rodriguez-Vida, Alejo; Bamias, Aristotelis; Esteban, Emilio; Isabel Saez, Maria; Lopez-Brea, Marta; Castellano, Daniel; Caballero, Cristina; Luis Gonzalez-Larriba, Jose; Calvo, Emiliano; Macia, Sonia; Ravaud, Alain; Bellmunt, Joaquim BJU INTERNATIONAL 1464-4096 (2020) DOI / 10.1111/bju.15165
Mentions   0   Wikipedia   0   News   0   Policy
Article BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer Martinez, Victor G.; Rubio, Carolina; Martinez-Fernandez, Monica; Segovia, Cristina; Lopez-Calderon, Fernando; Garin, Marina I.; Teijeira, Alicia; Munera-Maravilla, Ester; Varas, Alberto; Sacedon, Rosa; Guerrero, Felix; Villacampa, Felipe; de la Rosa, Fede CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-17-1004 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE) Nunez-Valdovinos, Barbara; Carmona-Bayonas, Alberto; Jimenez-Fonseca, Paula; Capdevila, Jaume; Castano-Pascual, Angel; Benavent, Marta; Pi Barrio, Jose Javier; Teule, Alex; Alonso, Vicente; Custodio, Ana; Marazuela, Monica; Segura, Angel; Beguiristain, Ado ONCOLOGIST 1083-7159 (2018) DOI / 10.1634/theoncologist.2017-0364 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer Gonzalez-Billalabeitia, Enrique; Manuel Sepulveda, Juan; Maroto, Pablo; Aparicio, Jorge; Angel Arranz, Jose; Esteban, Emilio; Girones, Regina; Lopez-Brea, Marta; Jose Mendez-Vidal, Maria; Pinto, Alvaro; Sastre, Javier; Soto de Prado, Diego; Terrasa, Josefa EUROPEAN UROLOGY FOCUS (2017) DOI / 10.1016/j.euf.2016.07.002
Mentions   0   Wikipedia   0   News   0   Policy
Article Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer Bellmunt, J.; Eigl, B. J.; Senkus, E.; Loriot, Y.; Twardowski, P.; Castellano, D.; Blais, N.; Sridhar, S. S.; Sternberg, C. N.; Retz, M.; Pal, S.; Blumenstein, B.; Jacobs, C.; Stewart, P. S.; Petrylak, D. P. ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx400 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients Gonzalez-Billalabeitia, Enrique; Castellano, Daniel; Sobrevilla, Nora; Guma, Josep; Hervas, David; Luengo, Maria I.; Aparicio, Jorge; Sanchez-Munoz, Alfonso; Mellado, Begona; Saenz, Alberto; Valverde, Claudia; Fernandez, Antonio; Margeli, Mireia; Duran, Ig JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 0027-8874 (2017) DOI / 10.1093/jnci/djw265 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Urothelial cancer proteomics provides both prognostic and functional information De Velasco, Guillermo; Trilla-Fuertes, Lucia; Gamez-Pozo, Angelo; Urbanowicz, Maria; Ruiz-Ares, Gustavo; Sepulveda, Juan M.; Prado-Vazquez, Guillermo; Arevalillo, Jorge M.; Zapater-Moros, Andrea; Navarro, Hilario; Lopez-Vacas, Rocio; Manneh, Ray; Otero, Ir SCIENTIFIC REPORTS 2045-2322 (2017) DOI / 10.1038/s41598-017-15920-6 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma Trilla-Fuertes, Lucia; Miranda, Natalia; Castellano, Daniel; Lopez-Vacas, Rocio; Farfan Tello, Carlos A.; De Velasco, Guillermo; Villacampa, Felipe; Lopez-Camacho, Elena; Prado-Vazquez, Guillermo; Zapater-Moros, Andrea; Espinosa, Enrique; Fresno Vara, Juan PLOS ONE 1932-6203 (2020) DOI / 10.1371/journal.pone.0229075 Green submitted, Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3) Tran, Ben; Ruiz-Morales, Jose M.; Gonzalez-Billalabeitia, Enrique; Patrikidou, Anna; Amir, Eitan; Seidel, Christoph; Bokemeyer, Carsten; Fankhauser, Christian; Hermanns, Thomas; Rumyantsev, Alexey; Tryakin, Alexey; Brito, Margarida; Flechon, Aude; Kwan, Ed CANCER MEDICINE 2045-7634 (2019) DOI / 10.1002/cam4.2674 Gold DOAJ, Green published, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma Loriot, Yohann; Sternberg, Cora N.; Castellano, Daniel; Oosting, Sjoukje F.; Dumez, Herlinde; Huddart, Robert; Vianna, Karina; Gordoa, Teresa Alonso; Skoneczna, Iwona; Fay, Andre P.; Nole, Franco; Massari, Francesco; Brasiuniene, Birute; Maroto, Pablo; Fea EUROPEAN JOURNAL OF CANCER 0959-8049 (2020) DOI / 10.1016/j.ejca.2020.07.023
Mentions   0   Wikipedia   0   News   0   Policy
Article Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents Angelergues, Antoine; Efstathiou, Eleni; Gyftaki, Revekka; Wysocki, Piotr Jan; Lainez, Nuria; Gonzalez, Iria; Castellano, Daniel E.; Ozguroglu, Mustafa; Garcia Carbonero, Iciar; Flechon, Aude; Borrega, Pablo; Guillot, Aline; Campos Balea, Begona; Le Moulec CLINICAL GENITOURINARY CANCER 1558-7673 (2018) DOI / 10.1016/j.clgc.2018.02.016
Mentions   0   Wikipedia   0   News   0   Policy
Review Translational research in neuroendocrine tumors: pitfalls and opportunities Capdevila, J.; Casanovas, O.; Salazar, R.; Castellano, D.; Segura, A.; Fuster, P.; Aller, J.; Garcia-Carbonero, R.; Jimenez-Fonseca, P.; Grande, E.; Castano, J. P. ONCOGENE 0950-9232 (2017) DOI / 10.1038/onc.2016.316
Mentions   0   Wikipedia   0   News   0   Policy
Article A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOG Garcia-Donas, Jesus; Angel Leon, Luis; Esteban, Emilio.; Jose Vidal-Mendez, Maria; Angel Arranz, Jose; Garcia del Muro, Xavier; Basterretxea, Laura; Gonzalez del Alba, Aranzazu; Angel Climent, Miguel; Antonio Virizuela, Juan; Alvarez, Carlos; Sepulveda, Ju EUROPEAN UROLOGY FOCUS (2017) DOI / 10.1016/j.euf.2016.09.004
Mentions   0   Wikipedia   0   News   0   Policy
Article Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial Szabados, Bernadett; Rodriguez-Vida, Alejo; Duran, Ignacio; Crabb, Simon J.; van der Heijden, Michiel S.; Pous, Albert Font; Gravis, Gwenaelle; Herranz, Urbano Anido; Protheroe, Andrew; Ravaud, Alain; Maillet, Denis; Mendez-Vidal, Maria J.; Suarez, Cristin EUROPEAN UROLOGY ONCOLOGY (2021) DOI / 10.1016/j.euo.2020.11.010
Mentions   0   Wikipedia   0   News   0   Policy
Review Strategies to design clinical studies to identify predictive biomarkers in cancer research Perez-Gracia, Jose Luis; Sanmamed, Miguel F.; Bosch, Ana; Patino-Garcia, Ana; Schalper, Kurt A.; Segura, Victor; Bellmunt, Joaquim; Tabernero, Josep; Sweeney, Christopher J.; Choueiri, Toni K.; Martin, Miguel; Pablo Fusco, Juan; Esperanza Rodriguez-Ruiz, M CANCER TREATMENT REVIEWS 0305-7372 (2017) DOI / 10.1016/j.ctrv.2016.12.005 Gold other, Green published
Mentions   0   Wikipedia   0   News   1   Policy
Article Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study Faivre, S.; Niccoli, P.; Castellano, D.; Valle, J. W.; Hammel, P.; Raoul, J. -L.; Vinik, A.; Van Cutsem, E.; Bang, Y. -J.; Lee, S. -H.; Borbath, I.; Lombard-bohas, C.; Metrakos, P.; Smith, D.; Chen, J. -S.; Ruszniewski, P.; Seitz, J. -F.; Patyna, S.; Lu, D ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdw561 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy Fankhauser, Christian Daniel; Tran, Ben; Pedregal, Manuel; Ruiz-Morales, Jose Manuel; Gonzalez-Billalabeitia, Egon; Patrikidou, Anna; Amir, Eitan; Seidel, Christoph; Bokemeyer, Carsten; Hermanns, Thomas; Rumyantsev, Alexey; Tryakin, Alexey; Brito, Margarid EUROPEAN UROLOGY FOCUS (2021) DOI / 10.1016/j.euf.2020.09.017
Mentions   0   Wikipedia   0   News   0   Policy
Article Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib Cebrian, Arancha; Gomez del Pulgar, Teresa; Jose Mendez-Vidal, Maria; Luisa Gonzalvez, Maria; Lainez, Nuria; Castellano, Daniel; Garcia-Carbonero, Iciar; Esteban, Emilio; Isabel Saez, Maria; Villatoro, Rosa; Suarez, Cristina; Carrato, Alfredo; Munarriz-Fer SCIENTIFIC REPORTS 2045-2322 (2017) DOI / 10.1038/srep41371 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma Wei, Xiao X.; Werner, Lillian; Teo, Min Y.; Rosenberg, Jonathan E.; Koshkin, Vadim S.; Grivas, Petros; Szabados, Bernadett; Morrison, Laura; Powles, Thomas; Carril-Ajuria, Lucia; Castellano, Daniel; Velho, Pedro Isaacsson; Hahn, Noah M.; McKay, Rana R.; Ra JOURNAL OF UROLOGY 0022-5347 (2021) DOI / 10.1097/ju.0000000000001371
Mentions   0   Wikipedia   0   News   0   Policy
Review Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care Castellano, Daniel; Pablo Maroto, Jose; Benzaghou, Fawzi; Taguieva, Naila; Linh Nguyen; Clary, Douglas O.; Jonasch, Eric CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2020.102062 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study Capdevila, Jaume; Teule, Alexandre; Barriuso, Jorge; Castellano, Daniel; Lopez, Carlos; Luis Manzano, Jose; Alonso, Vicente; Garcia-Carbonero, Rocio; Dotor, Emma; Matos, Ignacio; Custodio, Ana; Casanovas, Oriol; Salazar, Ramon ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2017-0622 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis. Carretero-Gonzalez, Alberto; Otero, Irene; Lora, David; Carril-Ajuria, Lucia; Castellano, Daniel; De Velasco, Guillermo ONCOIMMUNOLOGY 2162-4011 (2021) DOI / 10.1080/2162402x.2021.1878599 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer Caries, Joan; Castellano, Daniel; Mendez-Vidal, Maria-Jose; Mellado, Begona; Saez, Maria-Isabel; Gonzalez del Alba, Aranzazu; Perez-Gracia, Jose-Luis; Jimenez, Jose; Suarez, Cristina; Sepulveda, Juan M.; Manneh, Ray; Porras, Ignacio; Lopez, Cristina; Moral CLINICAL GENITOURINARY CANCER 1558-7673 (2018) DOI / 10.1016/j.clgc.2018.07.013
Mentions   0   Wikipedia   0   News   0   Policy
Article Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma Bedke, Jens; Merseburger, Axel S.; Loriot, Yohann; Castellano, Daniel; Choy, Ernest; Duran, Ignacio; Rosenberg, Jonathan E.; Petrylak, Daniel P.; Dreicer, Robert; Perez-Gracia, Jose L.; Hoffman-Censits, Jean H.; van der Heijden, Michiel S.; Pavlova, Julie; EUROPEAN UROLOGY FOCUS (2021) DOI / 10.1016/j.euf.2020.10.009
Mentions   0   Wikipedia   0   News   0   Policy
Article Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer Hakenberg, Oliver W.; Perez-Gracia, Jose Luis; Castellano, Daniel; Demkow, Tomasz; Ali, Tarek; Caffo, Orazio; Heidenreich, Axel; Schultze-Seemann, Wolfgang; Sautois, Brieuc; Pavlik, Ivan; Qin, Amy; Novosiadly, Ruslan D.; Shahir, Ashwin; Ilaria, Robert, Jr. EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2018.10.005
Mentions   0   Wikipedia   0   News   0   Policy
Letter Challenges of treatment selection in the older prostate patient Carretero Gonzalez, Alberto; Cruz Martin, Maria; Luyo, Marianne; Castellano, Daniel; De Velasco, Guillermo JOURNAL OF GERIATRIC ONCOLOGY 1879-4068 (2019) DOI / 10.1016/j.jgo.2019.01.009
Mentions   0   Wikipedia   0   News   0   Policy
Article Radium-223 international early access program: results from the Spanish subset Carles, Joan; Jose Mendez, Ma; Pinto, Alvaro; Isabel Saez, Ma; Arranz, Jose A.; Maroto, Pablo; Lopez-Criado, Pilar; Mellado, Begona; Garcia Donas, Jesus; Hernando, Susana; Leon, Luis; Gonzalez del Alba, Aranzazu; Lainez, Nuria; Esteban, Emilio; Reynes, Gas FUTURE ONCOLOGY 1479-6694 (2018) DOI / 10.2217/fon-2017-0297
Mentions   0   Wikipedia   0   News   0   Policy
Article Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study Luis Perez-Gracia, Jose; Castellano, Daniel; Angel Climent, Miguel; Mellado, Begona; Suarez, Cristina MEDICAL ONCOLOGY 1357-0560 (2019) DOI / 10.1007/s12032-019-1251-7
Mentions   0   Wikipedia   0   News   0   Policy
Article Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma Puente, Javier; Lainez, Nuria; Duenas, Marta; Jose Mendez-Vidal, Maria; Esteban, Emilio; Castellano, Daniel; Martinez-Fernandez, Moica; Basterretxea, Laura; Jose Juan-Fita, Maria; Anton, Luis; Leon, Luis; Lambea, Julio; Perez-Valderrama, Begona; Vazquez, S ONCOTARGET 1949-2553 (2017) DOI / 10.18632/oncotarget.16494 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Review Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series Bamias, Aristotelis; Hegele, Axel; Medioni, Jacques; Castellano, Daniel; Doni, Laura; Passalacqua, Rodolfo; Zagouri, Flora; Tzannis, Kimon; Hussain, Syed; Ullen, Anders CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 1040-8428 (2019) DOI / 10.1016/j.critrevonc.2019.05.006 Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Review Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news Zambrana, Francisco; Carril-Ajuria, Lucia; de Liano, Alfonso Gomez; Chanza, Nieves Martinez; Manneh, Ray; Castellano, Daniel; De Velasco, Guillermo CANCER TREATMENT REVIEWS 0305-7372 (2021) DOI / 10.1016/j.ctrv.2021.102239
Mentions   0   Wikipedia   0   News   0   Policy
Article SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy Bamias, A.; Merseburger, A. S.; Loriot, Y.; James, N.; Choy, E.; Castellano, D.; Lopez-Rios, F.; Calabro, F.; Kramer, M.; De Velasco, G.; Zakopoulou, R.; Tzannis, K.; Sternberg, C. N. ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100152 Green accepted, Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma Liu, Xiaoyan; Swen, Jesse J.; Diekstra, Meta H. M.; Boven, Epie; Castellano, Daniel; Gelderblom, Hans; Mathijssen, Ron H. J.; Vermeulen, Sita H.; Oosterwijk, Egbert; Junker, Kerstin; Roessler, Max; Alexiusdottir, Kristin; Sverrisdottir, Asgerdur; Radu, Mar CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-2815 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating Levels of the Interferon-gamma-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy Esteban, Emilio; Exposito, Francisco; Crespo, Guillermo; Lambea, Julio; Pinto, Alvaro; Puente, Javier; Arranz, Jose A.; Redrado, Miriam; Rodriguez-Antona, Cristina; de Andrea, Carlos; Lopez-Brea, Marta; Redin, Esther; Rodriguez, Angel; Serrano, Diego; Garc CANCERS (2021) DOI / 10.3390/cancers13112849 Gold DOAJ, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease Suzuki, Hiroyoshi; Castellano, Daniel; de Bono, Johann; Sternberg, Cora N.; Fizazi, Karim; Tombal, Bertrand; Wulfing, Christian; Foster, Meredith C.; Ozatilgan, Ayse; Geffriaud-Ricouard, Christine; de Wit, Ronald JAPANESE JOURNAL OF CLINICAL ONCOLOGY 0368-2811 (2021) DOI / 10.1093/jjco/hyab028 Hybrid, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer Massard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Gonzalez, Begona Mellado; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim EUROPEAN JOURNAL OF CANCER 0959-8049 (2017) DOI / 10.1016/j.ejca.2017.01.024
Mentions   0   Wikipedia   0   News   0   Policy
Article Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials Carretero-Gonzalez, A.; Lora, D.; Manneh, R.; Lorente, D.; Castellano, D.; De Velasco, G. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02334-6
Mentions   0   Wikipedia   0   News   0   Policy
Review Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With AntiePD-1/PD-L1 Therapy Carril-Ajuria, Lucia; Lora, David; Carretero-Gonzalez, Alberto; Martin-Soberon, Maricruz; Rioja-Viera, Patricia; Castellano, Daniel; De Velasco, Guillermo CLINICAL GENITOURINARY CANCER 1558-7673 (2021) DOI / 10.1016/j.clgc.2020.10.004

Más rankings

InfluScience

Contacto
Cerrar